Your browser doesn't support javascript.
loading
Poorly differentiated muscle-invasive giant cell tumor of the bladder leads to unfavorable clinical outcome.
Karasavvidou, Foteini; Mitrakas, Lampros; Strataki, Maria; Anastasiou, Dimitrios; Koukoulis, Georgios; Tzortzis, Vassilios.
Afiliação
  • Karasavvidou F; Department of Pathology and Cytology, Faculty of Medicine-School of Health Sciences-University of Thessaly, University Hospital of Larissa, Larissa, Greece.
  • Mitrakas L; Department of Urology, Faculty of Medicine-School of Health Sciences-University of Thessaly, University Hospital of Larissa, Larissa, Greece.
  • Strataki M; Department of Pathology and Cytology, Faculty of Medicine-School of Health Sciences-University of Thessaly, University Hospital of Larissa, Larissa, Greece.
  • Anastasiou D; Department of Urology, Faculty of Medicine-School of Health Sciences-University of Thessaly, University Hospital of Larissa, Larissa, Greece.
  • Koukoulis G; Department of Pathology and Cytology, Faculty of Medicine-School of Health Sciences-University of Thessaly, University Hospital of Larissa, Larissa, Greece.
  • Tzortzis V; Department of Urology, Faculty of Medicine-School of Health Sciences-University of Thessaly, University Hospital of Larissa, Larissa, Greece.
J Surg Case Rep ; 2022(4): rjac046, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35422996
ABSTRACT
Urothelial carcinoma of the urinary bladder is a common clinical entity. Recently, researchers focused on the emerging clinical significance of histologic variants, because they may need special therapy and their prognosis differs. Hereby, we describe a case of a giant cell osteoclast-like urothelial carcinoma of the urinary bladder.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article